This defect allows the virus to selectively infect tumour cells, which may be due to the dysregulation of interferon receptor expression, resulting in responsiveness to antiviral enzymes and damage to STAT1 signalling 25, 26. This evidence concerns the gene STAT1 and neoplasm.